Comparison

Natalizumab (ITGA4/CD49d) Antibody, Monoclonal

Item no. PRS-10-090-0.1mg
Manufacturer ProSci
Amount 0.1 mg
Category
Type Antibody Monoclonal
Specific against other
Isotype IgG4 Kappa
Conjugate/Tag Unconjugated
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Alias AN 100226,BG00002, ITGA4/CD49d, ITGA4/CD49d
Available
Shipping Temperature
blue ice or room temperature
Storage Conditions
Store at -80°C
Manufacturer - Research Area
Drug Analogues
Background
Natalizumab is a recombinant, humanized monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1).Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses.
Purification
>95%
Buffer
PBS buffer pH7.5
Immunogen
Humanized / ITGA4/CD49d [Homo sapiens]
Clonality
Monoclonal
NCBI Organism
homo sapiens
Disclaimer
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close